Annual Report

Overview

The report presents Lincoln Pharmaceuticals as an affordable-healthcare pharmaceutical company with a 65% clean-energy claim, detailed FY2022-23 BRSR disclosures, and quantified Scope 1, Scope 2 and Scope 3 emissions. It also reports 1,645 year-end employees in the BRSR and CSR expenditure of ₹153.13 Lakhs. The report combines operational, environmental and social disclosures with consolidated financial statements for the year ended March 31, 2023.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services